This proliferative effect of NRF2 in cancer and non-cancer cells requires the presence of active PI3K/AKT signaling, where it seems that activation of the PI3K/AKT pathway increases NRF2 pathway activation and vice versa, constituting positive feedback (Mitsuishi et al, 2012). The gene discussed is AKT1; the disease is cancer.